Search Results - "GESTIN, C."

Nitrate, a signal relieving seed dormancy in Arabidopsis by ALBORESI, A., GESTIN, C., LEYDECKER, M.‐T., BEDU, M., MEYER, C., TRUONG, H.‐N.

“…ABSTRACT Nitrate is an important nitrogen source for plants, but also a signal molecule that controls various aspects of plant development. In the present…”
Get full text

Efficacy of bevacizumab in combination with irinotecan or oxaliplatin as second-line, third-line or later treatment in metastatic colorectal cancer (MCRC) patients by Lièvre, A., Samalin, E., Senesse, P., Boyer-Gestin, C., Mitry, E., Lepère, C., Bachet, J., Vaillant, J., Ychou, M., Rougier, P.

“…Abstract only 14558 Introduction: Bevacizumab (Bev) is efficient in MCRC patients (pts) as first-line treatment (L1) with 5FU±irinotecan, and with FOLFOX as…”
Get full text

Non-cross-reactive monoclonal antibodies to human chorionic gonadotropin generated after immunization with a synthetic peptide by Caraux, J, Chichehian, B, Gestin, C, Longhi, B, Lee, AC, Powell, JE, Stevens, VC, Pourquier, A

“…Noncross-reactive monoclonal antibodies specific for human chorionic gonadotropin (hCG) were obtained after pre-selection for submolecular specificity with a…”
Get full text

A phase I trial of a bi-weekly combination of capecitabine/irinotecan (XELIRI) then capecitabine/irinotecan/oxaliplatin (XELIRINOX) in solid tumors by Assenat, E., Kramar, A., Poujol, S., Gestin-Boyer, C., Senesse, P., Samalin, E., Portales, F., Thezenas, S., Bleuse, J., Ychou, M.

“…Abstract only e15075 Background: Oral fluoropyrimidines, notably capecitabine, are increasingly replacing IV 5-FU/LV as the backbone of therapy for metastatic…”
Get full text

Validation of a new interactive software monitoring a controlled-flow infusion pump for cisplatin dosage regimen adjustment by Cupissol, D, Brès, J, Gestin-Boyer, C, Nouguier-Soulé, J, Vian, L, Tep, A, Nouguier, J

“…Adaptive dosing of cisplatin (CDDP) results in reduced haematological and renal toxicity but it has never been clearly shown that it affects the tumoral…”
Get more information

Tumor-tissue and plasma concentrations of platinum during chemotherapy of non-small-cell lung cancer patients by PUJOL, J.-L, CUPISSOL, D, GESTIN-BOYER, C, BRES, J, SERROU, B, MICHEL, F.-B

“…Tumor-tissue and plasma concentrations of platinum were studied prospectively in two groups of eight patients who were suffering from advanced non-small-cell…”
Get full text

Ultradian variations of interleukin-1 beta concentration (IL-1 beta), interferon gamma (IFN-gamma) and soluble IL-2 receptors (RIL-2) in healthy volunteers humen by Bouayad-Amine, D, Cupissol, D, Nougier-Soule, J, Bres, J, Gestin-Boyer, C, René, C, Assens, C, Serrou, B

“…The aim of this study consisted in underlining the concentrations' evolution in time of two cytokines: IL-1 beta and IFN-gamma, as well as that of RIL-2…”
Get more information

Prevention of cisplatin nephrotoxicity in cancer: adjusting the dosage with a computerized chrono-pump by Gestin-Boyer, C, René, C, Cupissol, D, Tep, A, Bressolle, F, Bres, J, Brun, S, Serrou, B, Pujol, H

“…Platinum and its derivates are particularly efficient in treatment of ovarian and testis carcinomas. Nevertheless, the high nephrotoxicity of these drugs…”
Get more information